» Articles » PMID: 19617745

Tumor Subsite Location Within the Colon is Prognostic for Survival After Colon Cancer Diagnosis

Overview
Specialty Gastroenterology
Date 2009 Jul 21
PMID 19617745
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Proximal colon cancers are more likely to present with advanced stage than distal cancers; however, previous reports conflict regarding the independent prognostic significance of tumor location on survival. We examined survival by colon cancer subsite location by use of data from the California Cancer Registry.

Methods: An analysis of colon cancer cases from 1994 to 2004 was conducted, with follow-up through 2006. Colon subsite location was defined as proximal colon (cecum, ascending colon, hepatic flexure), transverse colon, descending colon (splenic flexure, descending colon), and sigmoid colon. Subsite-specific survival analyses were conducted with use of the Kaplan-Meier method and Cox proportional hazards ratios.

Results: A total of 82,926 colon cancer cases were identified, including 40,078 proximal (48%), 8,023 transverse (10%), 8,657 descending (10%), and 26,168 sigmoid cancers (32%). A larger proportion of sigmoid cancers (30.5%) presented as Stage I compared with proximal (18.5%), transverse (16.8%), or descending colon cancers (20.1%). Proximal cancers had the greater proportion with high tumor grade (27%), and had a greater mean number of lymph nodes examined. There were no differences in treatment rendered when each colon subsite was stratified by stage. After adjustment for stage, grade, treatment, lymph node examination, and other relevant clinical variables, sigmoid cancers had decreased colorectal cancer-specific mortality compared with proximal tumors (hazards ratio = 0.88; 95% confidence interval, 0.85-0.92).

Conclusions: In this analysis, sigmoid colon cancers were observed to have earlier stage, lower tumor grade, and independently decreased colorectal cancer-specific mortality compared with proximal tumors.

Citing Articles

Incidence and determinants of mortality among patients with colorectal cancer in oncology centers of Amhara region, Ethiopia, 2024: multicenter retrospective follow up study.

Walle G, Kitaw T, Adane S BMC Cancer. 2025; 25(1):102.

PMID: 39827340 PMC: 11742809. DOI: 10.1186/s12885-025-13462-z.


miR‑106b‑5p in stage II left‑sided and right‑sided colon cancer and its association with the prognostic characteristics of patients.

Zhou S, Sui W, Wang Y, Zhong G, Yuan X Oncol Lett. 2024; 29(1):11.

PMID: 39526305 PMC: 11544695. DOI: 10.3892/ol.2024.14758.


Oncologic outcomes and trends in each colon cancer location and stages over the last two decades: insights from the SEER registry.

Benlice C, Elhan A, Seker M, Gorgun E, Kuzu M Tech Coloproctol. 2024; 28(1):147.

PMID: 39487239 DOI: 10.1007/s10151-024-03020-3.


Right-sided versus left-sided colorectal cancer in elderly patients: a sub-analysis of a large multicenter case-control study in Japan.

Sada H, Hinoi T, Niitsu H, Ohdan H, Yamamoto S, Endo S Surg Today. 2024; 54(10):1173-1183.

PMID: 38839654 PMC: 11413077. DOI: 10.1007/s00595-024-02827-9.


Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials.

Solar Vasconcelos J, Chen N, Titmuss E, Tu D, Brule S, Goodwin R Clin Cancer Res. 2024; 30(6):1121-1130.

PMID: 38170586 PMC: 10940852. DOI: 10.1158/1078-0432.CCR-23-3275.